Cargando…
Multiple endocrine neoplasia type 4: a new member of the MEN family
OBJECTIVE: Multiple endocrine neoplasia type 4 (MEN4) is caused by a CDKN1B germline mutation first described in 2006. Its estimated prevalence is less than one per million. The aim of this study was to define the disease characteristics. METHODS: A systematic review was performed according to the P...
Autores principales: | Singeisen, Hélène, Renzulli, Mariko Melanie, Pavlicek, Vojtech, Probst, Pascal, Hauswirth, Fabian, Muller, Markus K, Adamczyk, Magdalene, Weber, Achim, Kaderli, Reto Martin, Renzulli, Pietro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874964/ https://www.ncbi.nlm.nih.gov/pubmed/36520683 http://dx.doi.org/10.1530/EC-22-0411 |
Ejemplares similares
-
Adrenal myelolipoma: Defining the role of surgery. A case report
por: Steka, Xanthi, et al.
Publicado: (2022) -
Intertumor heterogeneity in 60 pancreatic neuroendocrine tumors associated with multiple endocrine neoplasia type 1
por: Selberherr, Andreas, et al.
Publicado: (2019) -
Minimally invasive versus open pancreatic surgery: meta-analysis of randomized clinical trials
por: Pfister, Matthias, et al.
Publicado: (2023) -
Multiple Endocrine Neoplasia
por: Heath, David
Publicado: (1998) -
Imaging diagnostic standard in multiple endocrine neoplasia (MEN)
por: Tesdorff, J, et al.
Publicado: (2014)